Everything you need to know
about biosimilars in one place

Prescribers, Pharmacists and Patients: Negotiating the Issues Around Biosimilars

  With Zarxio’s entry into the U.S. market still pending, pharmacists need to be aware of biosimilars in order to better assist their patients.   While the U.S.’s first approved biosimilar, Zarxio is yet to be available to prescribers and patients amid ongoing legal battles, the fact is that biosimilars will soon be a reality … Continue reading Prescribers, Pharmacists and Patients: Negotiating the Issues Around Biosimilars

Read more